BIOUX
Price
$57.13
Change
-$1.54 (-2.62%)
Updated
Nov 13 closing price
Net Assets
1.72B
GAFFX
Price
$87.43
Change
-$1.96 (-2.19%)
Updated
Nov 13 closing price
Net Assets
340.4B
Interact to see
Advertisement

BIOUX vs GAFFX

Header iconBIOUX vs GAFFX Comparison
Open Charts BIOUX vs GAFFXBanner chart's image
Baron Opportunity R6
Price$57.13
Change-$1.54 (-2.62%)
VolumeN/A
Net Assets1.72B
American Funds Growth Fund of Amer F3
Price$87.43
Change-$1.96 (-2.19%)
VolumeN/A
Net Assets340.4B
BIOUX vs GAFFX Comparison Chart in %
View a ticker or compare two or three
VS
BIOUX vs. GAFFX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOUX is a StrongBuy and GAFFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 340B vs. BIOUX (1.72B). GAFFX pays higher dividends than BIOUX: GAFFX (0.56) vs BIOUX (0.00). BIOUX was incepted earlier than GAFFX: BIOUX (9 years) vs GAFFX (9 years). BIOUX (1.05) is less costly to investors than GAFFX (0.30). BIOUX is a more actively managed with annual turnover of: 33.00 vs. GAFFX (25.00). GAFFX has a lower initial minimum investment than BIOUX: GAFFX (1000000) vs BIOUX (5000000). BIOUX annual gain was more profitable for investors over the last year : 13.57 vs. GAFFX (9.29). BIOUX return over 5 years is better than : 49.59 vs. GAFFX (41.94).
BIOUXGAFFXBIOUX / GAFFX
Total Expense Ratio1.050.30350%
Annual Report Gross Expense Ratio1.050.30350%
Fund Existence9 years9 years-
Gain YTD16.11120.03580%
Front LoadN/AN/A-
Min. Initial Investment50000001000000500%
Min. Initial Investment IRAN/AN/A-
Net Assets1.72B340B1%
Annual Yield % from dividends0.000.56-
Returns for 1 year13.579.29146%
Returns for 3 years115.1566.27174%
Returns for 5 years49.5941.94118%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZLDPF78.725.44
+7.42%
Zealand Pharma A/S
SWSDF1082.09N/A
N/A
Swiss Life Holding
SOBS30.36N/A
N/A
Solvay Bank (NY)
SWDHF0.52N/A
N/A
Skyworth Group Limited
ONEI0.18-0.06
-25.32%
OneMeta Inc.